DepoMed, Inc. (DEPO) Tops Q4 EPS by 4c

DepoMed, Inc. (NASDAQ: DEPO) reported Q4 EPS of ($0.25), $0.04 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $12.1 million versus the consensus estimate of $10.88 million.

For earnings history and earnings-related data on DepoMed, Inc. (DEPO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• DA Davidson Assumes Knife River Corp. (KNF) at Buy
• Morgan Stanley Downgrades Nichirei Corp (2871:JP) to Equalweight
• UBS Reiterates Neutral Rating on Green Plains Renewable Energy (GPRE)